Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: Results from the CaMos and Manitoba cohorts

Osteoporosis International

Volumn 22, Issue 6, 2011, Pages 1873-1883

  Leslie, W D ^a,m   Berger, C ^b   Langsetmo, L ^b   Lix, L M ^c   Adachi, J D ^d   Hanley, D A ^e   Ioannidis, G ^d   Josse, R G ^f   Kovacs, C S ^g   Towheed, T ^h   Kaiser, S ⁱ   Olszynski, W P ^j   Prior, J C ^k   Jamal, S ^f   Kreiger, N ^c,l   Goltzman, D ^b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^h QUEEN S UNIVERSITY   (Canada)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j UNIVERSITY OF SASKATCHEWAN   (Canada)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^l UNIVERSITY OF TORONTO   (Canada)

^m ST BONIFACE GENERAL HOSPITAL   (Canada)

more..

Author keywords

Bone mineral density; Canada; CAROC; Fracture risk prediction; FRAX; Osteoporosis

Indexed keywords

ETANERCEPT; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE;

ADULT; AGE; AGED; BONE DENSITY; CALIBRATION; CANADA; CLASSIFICATION; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FAMILY HISTORY; FEMALE; FEMUR NECK; FOREARM FRACTURE; FRACTURE RISK ASSESSMENT TOOL; FRAGILITY FRACTURE; GENDER; HIGH RISK PATIENT; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMOKING; SYSTEMIC THERAPY; VERTEBRA FRACTURE;

ADULT; AGE FACTORS; AGED; BONE DENSITY; FEMALE; FEMUR NECK; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS;

EID: 79959926442     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1445-5     Document Type: Conference Paper

References (36)

1. Kanis JA, Melton LJ III, Christiansen C et al (1994) The diagnosis of osteoporosis [see comments]. J Bone Miner Res 9:1137-41
2. Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468-89 (Pubitemid 28486716)
3. Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42:467-75
4. Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108-12 (Pubitemid 38668990)
5. Cranney A, Jamal SA, Tsang JF et al (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177:575-80 (Pubitemid 47437054)
6. Langsetmo L, Goltzman D, Kovacs CS et al (2009) Repeat lowtrauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 24:1515-22
7. Siminoski K, Leslie WD, Frame H et al (2007) Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom 10:120-3 (Pubitemid 46680553)
8. Kanis JA, Johnell O, Oden A et al (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989-95 (Pubitemid 34105967)
9. Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375-82 (Pubitemid 38953182)
10. Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893-9 (Pubitemid 41103445)
11. Adachi JD, Olszynski WP, Hanley DA et al (2000) Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 29:228-51 (Pubitemid 30108097)
12. Leslie WD, Tsang JF, Lix LM (2009) Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res 24:353-60
13. Leslie WD, Lix LM (2010) Simplified 10-year absolute fracture risk assessment: a comparison of men and women. J Clin Densitom 13:141-6
14. Leslie WD, O'Donnell S, Jean S et al (2009) Trends in hip fracture rates in Canada. JAMA 302:883-9
15. Kanis JA, Oden A, Johansson H et al (2009) FRAX and its applications to clinical practice. Bone 44:734-43
16. Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033-46 (Pubitemid 47020000)
17. Leslie WD, Lix D, Langsetmo L, et al. (2010) Construction of a FRAX model for the assessment of fracture probability in Canada and implications for treatment. Osteoporis Int (in press)
18. Chen P, Krege JH, Adachi JD et al (2009) Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res 24:495-502
19. Kreiger N, Tenenhouse A, Joseph L et al (1999) Research notes: the Canadian Multicentre Osteoporosis Study (CaMos) - background, rationale, methods. Can J Aging 18:376-87
20. Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385-97
21. Berger C, Langsetmo L, Joseph L et al (2009) Association between change in BMD and fragility fracture in women and men. J Bone Miner Res 24:361-70
22. Genant HK, Grampp S, Gluer CC et al (1994) Universal standardization for dual x-ray absorptiometry: Patient and phantom cross-calibration results. J Bone Miner Res 9:1503-14 (Pubitemid 24300099)
23. Roos NP, Shapiro E (1999) Revisiting the manitoba centre for health policy and evaluation and its population-based health information system. Med Care 37: JS10-JS14
24. WHO Collaborating Centre for Drug Statistics Methodology (2005) Guidelines for ATC classification and DDD assignment. Norwegian Institute for Public Health, Oslo
25. Kozyrskyj AL, Mustard CA (1998) Validation of an electronic, population-based prescription database. Ann Pharmacother 32:1152-7 (Pubitemid 28543459)
26. Leslie WD, Tsang JF, Caetano PA et al (2007) Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 92:77-81 (Pubitemid 46067512)
27. Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275-82 (Pubitemid 37194011)
28. Leslie WD, MacWilliam L, Lix L et al (2005) A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 16:773-82 (Pubitemid 40941013)
29. Leslie WD, Caetano PA, MacWilliam LR et al (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25-30 (Pubitemid 40392924)
30. Leslie WD (2006) The importance of spectrum bias on bone density monitoring in clinical practice. Bone 39:361-8 (Pubitemid 43851370)
31. Janes H, Pepe MS, Gu W (2008) Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 149:751-60
32. Siminoski K, Leslie WD, Frame H et al (2005) Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56:178-88 (Pubitemid 41133860)
33. Leslie WD, O'Donnell S, Lagace C et al (2009) Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int 21:1317-1322
34. Kanis JA, Johnell O, De Laet C et al (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237-44 (Pubitemid 34680500)
35. Fraser L, Langsetmo L, Berger C et al (2010). Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporis Int (in press)
36. Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX ((R)) tool: Fracture prediction and model calibration. J Bone Miner Res. doi:10.1002/jbmr.123